0001958173-22-000001.txt : 20221214 0001958173-22-000001.hdr.sgml : 20221214 20221214160622 ACCESSION NUMBER: 0001958173-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221214 DATE AS OF CHANGE: 20221214 EFFECTIVENESS DATE: 20221214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orion Therapeutics, Inc. CENTRAL INDEX KEY: 0001958173 IRS NUMBER: 882189627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-467444 FILM NUMBER: 221462171 BUSINESS ADDRESS: STREET 1: 2641 OSPREY VISTA WAY STREET 2: LAB 150A CITY: KNOXVILLE STATE: TN ZIP: 37920 BUSINESS PHONE: 865-771-7024 MAIL ADDRESS: STREET 1: 2641 OSPREY VISTA WAY STREET 2: LAB 150A CITY: KNOXVILLE STATE: TN ZIP: 37920 D 1 primary_doc.xml X0708 D LIVE 0001958173 Orion Therapeutics, Inc. 2641 OSPREY VISTA WAY LAB 150A KNOXVILLE TN TENNESSEE 37920 865-771-7024 DELAWARE None None Corporation true 2022 Richard Kern Fisher 2641 Osprey Vista Way Lab 150A Knoxville TN TENNESSEE 37920 Executive Officer Director Michael McCaman 2641 Osprey Vista Way Lab 150A Knoxville TN TENNESSEE 37920 Executive Officer Director Deidra Mountain 2641 Osprey Vista Way Lab 150A Knoxville TN TENNESSEE 37920 Director Biotechnology No Revenues 06b false 2022-11-30 false true false 0 250000 60000 190000 true 2 1 0 0 30800 true false Orion Therapeutics, Inc. /R. Scott Evans/ R. Scott Evans Attorney 2022-12-14